ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)

K. L. Winthrop, X. Mariette, J. T. Silva, E. Benamu, L. H. Calabrese, A. Dumusc, J. S. Smolen, J. M. Aguado, M. Fernández-Ruiz

Research output: Contribution to journalReview articlepeer-review

84 Scopus citations

Fingerprint

Dive into the research topics of 'ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)'. Together they form a unique fingerprint.

Medicine & Life Sciences